Cite
MLA Citation
Maria Gonzalez-Cao et al.. “Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy.” Melanoma research, vol. 28, no. 3, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100084037012.0x00001c